Incidence and risk of lung cancer in HIV-infected patients Wenli HouJun FuShucheng Hua Review 28 July 2013 Pages: 1781 - 1794
Uncovering a key to the process of metastasis in human cancers: a review of critical regulators of anoikis Kevin TanDavid GoldsteinJia-Lin Yang Review 04 August 2013 Pages: 1795 - 1805
Meeting report of the 4th Heidelberg Myeloma Workshop: Current status and developments in diagnosis and therapy of multiple myeloma Jens HillengassMerz MaximilianHartmut Goldschmidt Special Issue Manuscript 18 July 2013 Pages: 1807 - 1811
RUNX3 is a prognostic marker and potential therapeutic target in human breast cancer Jin BaiHong-Mei YongJun-Nian Zheng Original Paper 04 September 2013 Pages: 1813 - 1823
Postchemoradiation laparoscopic resection and intraoperative electron-beam radiation boost in locally advanced rectal cancer: long-term outcomes Felipe A. CalvoClaudio V. SoleEmilio del Valle Original Paper 05 September 2013 Pages: 1825 - 1833
Tetraspanin CD151 expression associated with prognosis for patients with advanced gastric cancer Byung Woog KangDakeun LeeYoung-Bae Kim Original Paper 05 September 2013 Pages: 1835 - 1843
The appearance of Tregs in cancer nest is a promising independent risk factor in colon cancer Wei XuHao LiuJun-Nian Zheng Original Paper 05 September 2013 Pages: 1845 - 1852
Comparison of laparoscopy and laparotomy for management of endometrial carcinoma: a prospective randomized study with 11-year experience Qi LuHaiyan LiuZhenyu Zhang Original Paper 06 September 2013 Pages: 1853 - 1859
Loss of chromosome 4 correlates with better long-term survival and lower relapse rate after R0-resection of colorectal liver metastases Nadine AustSilke SchüleThomas Liehr Original Paper 06 September 2013 Pages: 1861 - 1867
Identification of prognostic immunophenotypic features in cancer stromal cells of high-grade neuroendocrine carcinomas of the lung Akiko TakahashiGenichiro IshiiAtsushi Ochiai Original Paper 07 September 2013 Pages: 1869 - 1878
Intron 3 of the ARID5B gene: a hot spot for acute lymphoblastic leukemia susceptibility Ángela Gutiérrez-CaminoElixabet López-LópezÁfrica García-Orad Original Paper 08 September 2013 Pages: 1879 - 1886
Responsiveness of neoadjuvant chemotherapy before surgery predicts favorable prognosis for cervical cancer patients: a meta-analysis Qing YeHong-Xin YuanHong-Lin Chen Original Paper 11 September 2013 Pages: 1887 - 1898
Peritoneal metastases of lower gastrointestinal tract origin: a comparative study of patient outcomes following cytoreduction and intraperitoneal chemotherapy Lawson UngTerence C. ChuaDavid L. Morris Original Paper 11 September 2013 Pages: 1899 - 1908
Receptor change-clinicopathologic analysis of matched pairs of primary and cerebral metastatic breast cancer C. BachmannE. M. GrischkeD. Wallwiener Original Paper 14 September 2013 Pages: 1909 - 1916
Small molecule targeted therapies for the second-line treatment for metastatic renal cell carcinoma: a systematic review and indirect comparison of safety and efficacy George DranitsarisSusanne SchmitzReuben J. Broom Original Paper 14 September 2013 Pages: 1917 - 1926
Intensity-modulated adjuvant whole breast radiation delivered with static angle tomotherapy (TomoDirect): a prospective case series Pierfrancesco FrancoMichele ZeverinoUmberto Ricardi Original Paper 14 September 2013 Pages: 1927 - 1936
Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with relapsed or refractory multiple myeloma and light chain-induced renal failure Wolfram PönischBarbara MollDietger Niederwieser Original Paper 18 September 2013 Pages: 1937 - 1946
Comparison of metastatic lymph node ratio staging system with the 7th AJCC system for colorectal cancer Jizhun ZhangLiang LvShan Wang Original Paper 22 September 2013 Pages: 1947 - 1953
May non-metastatic clinically localized castration-resistant prostate cancer after primary androgen ablation benefit from salvage prostate radiotherapy? Angela BotticellaAlessia GuarneriUmberto Ricardi Original Paper 22 September 2013 Pages: 1955 - 1960
Erratum to: Cetuximab-induced skin exanthema: prophylactic and reactive skin therapy are equally effective Thomas C. WehlerClaudine GrafCarl C. Schimanski Erratum 20 September 2013 Pages: 1961 - 1962